229 related articles for article (PubMed ID: 25809486)
1. Dynamic Sialylation in Transforming Growth Factor-β (TGF-β)-induced Epithelial to Mesenchymal Transition.
Du J; Hong S; Dong L; Cheng B; Lin L; Zhao B; Chen YG; Chen X
J Biol Chem; 2015 May; 290(19):12000-13. PubMed ID: 25809486
[TBL] [Abstract][Full Text] [Related]
2. Integrin signaling potentiates transforming growth factor-beta 1 (TGF-β1) dependent down-regulation of E-Cadherin expression - Important implications for epithelial to mesenchymal transition (EMT) in renal cell carcinoma.
Feldkoren B; Hutchinson R; Rapoport Y; Mahajan A; Margulis V
Exp Cell Res; 2017 Jun; 355(2):57-66. PubMed ID: 28363829
[TBL] [Abstract][Full Text] [Related]
3. β-Galactoside α2,6-sialyltranferase 1 promotes transforming growth factor-β-mediated epithelial-mesenchymal transition.
Lu J; Isaji T; Im S; Fukuda T; Hashii N; Takakura D; Kawasaki N; Gu J
J Biol Chem; 2014 Dec; 289(50):34627-41. PubMed ID: 25344606
[TBL] [Abstract][Full Text] [Related]
4. Sanguiin H6 suppresses TGF-β induction of the epithelial-mesenchymal transition and inhibits migration and invasion in A549 lung cancer.
Ko H; Jeon H; Lee D; Choi HK; Kang KS; Choi KC
Bioorg Med Chem Lett; 2015 Dec; 25(23):5508-13. PubMed ID: 26508552
[TBL] [Abstract][Full Text] [Related]
5. MARVELD1 modulates cell surface morphology and suppresses epithelial-mesenchymal transition in non-small cell lung cancer.
Yao Y; Shi M; Liu S; Li Y; Guo K; Ci Y; Liu W; Li Y
Mol Carcinog; 2016 Nov; 55(11):1714-1727. PubMed ID: 26509557
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of Linc00511 inhibits TGF-β-induced cell migration and invasion by suppressing epithelial-mesenchymal transition and down-regulating MMPs expression.
Jiang L; Xie X; Bi R; Ding F; Mei J
Biomed Pharmacother; 2020 May; 125():109049. PubMed ID: 32092827
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effects of CD44 and TGF-β1 through AKT/GSK-3β/β-catenin signaling during epithelial-mesenchymal transition in liver cancer cells.
Park NR; Cha JH; Jang JW; Bae SH; Jang B; Kim JH; Hur W; Choi JY; Yoon SK
Biochem Biophys Res Commun; 2016 Sep; 477(4):568-574. PubMed ID: 27320862
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
[TBL] [Abstract][Full Text] [Related]
9. Glycan imaging in intact rat hearts and glycoproteomic analysis reveal the upregulation of sialylation during cardiac hypertrophy.
Rong J; Han J; Dong L; Tan Y; Yang H; Feng L; Wang QW; Meng R; Zhao J; Wang SQ; Chen X
J Am Chem Soc; 2014 Dec; 136(50):17468-76. PubMed ID: 25313651
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of SEMA4C Inhibit Epithelial-Mesenchymal Transition (EMT) and the Invasion and Metastasis of Cervical Cancer Cells via Inhibiting Transforming Growth Factor-beta 1 (TGF-β1)-Induced Hela cells p38 Mitogen-Activated Protein Kinase (MAPK) Activation.
Yang L; Yu Y; Xiong Z; Chen H; Tan B; Hu H
Med Sci Monit; 2020 Jan; 26():e918123. PubMed ID: 31951596
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-β1 induces epithelial-mesenchymal transition and integrin α3β1-mediated cell migration of HSC-4 human squamous cell carcinoma cells through Slug.
Saito D; Kyakumoto S; Chosa N; Ibi M; Takahashi N; Okubo N; Sawada S; Ishisaki A; Kamo M
J Biochem; 2013 Mar; 153(3):303-15. PubMed ID: 23248240
[TBL] [Abstract][Full Text] [Related]
12. Geraniin inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses A549 lung cancer migration, invasion and anoikis resistance.
Ko H
Bioorg Med Chem Lett; 2015 Sep; 25(17):3529-34. PubMed ID: 26169124
[TBL] [Abstract][Full Text] [Related]
13. The metastasis suppressor CD82/KAI1 represses the TGF-β
Lee MS; Lee J; Kim YM; Lee H
Prostate; 2019 Sep; 79(12):1400-1411. PubMed ID: 31212375
[TBL] [Abstract][Full Text] [Related]
14. Elevated TGF-β1 and -β2 expression accelerates the epithelial to mesenchymal transition in triple-negative breast cancer cells.
Kim S; Lee J; Jeon M; Nam SJ; Lee JE
Cytokine; 2015 Sep; 75(1):151-8. PubMed ID: 26088755
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Expression of Integrin αvβ3 Induced by TGF-β Is Required for the Enhancing Effect of Fibroblast Growth Factor 1 (FGF1) in TGF-β-Induced Epithelial-Mesenchymal Transition (EMT) in Mammary Epithelial Cells.
Mori S; Kodaira M; Ito A; Okazaki M; Kawaguchi N; Hamada Y; Takada Y; Matsuura N
PLoS One; 2015; 10(9):e0137486. PubMed ID: 26334633
[TBL] [Abstract][Full Text] [Related]
16. A complex between phosphatidylinositol 4-kinase IIα and integrin α3β1 is required for
Isaji T; Im S; Kameyama A; Wang Y; Fukuda T; Gu J
J Biol Chem; 2019 Mar; 294(12):4425-4436. PubMed ID: 30659093
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-β1 signaling promotes epithelial-mesenchymal transition-like phenomena, cell motility, and cell invasion in synovial sarcoma cells.
Qi Y; Wang N; He Y; Zhang J; Zou H; Zhang W; Gu W; Huang Y; Lian X; Hu J; Zhao J; Cui X; Pang L; Li F
PLoS One; 2017; 12(8):e0182680. PubMed ID: 28829837
[TBL] [Abstract][Full Text] [Related]
18. miR-130a-3p regulated TGF-β1-induced epithelial-mesenchymal transition depends on SMAD4 in EC-1 cells.
Tian X; Fei Q; Du M; Zhu H; Ye J; Qian L; Lu Z; Zhang W; Wang Y; Peng F; Chen J; Liu B; Li Q; He X; Yin L
Cancer Med; 2019 Mar; 8(3):1197-1208. PubMed ID: 30741461
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of SEPT9 inhibits glioma progression through suppressing TGF-β-induced epithelial-mesenchymal transition (EMT).
Zhang G; Feng W; Wu J
Biomed Pharmacother; 2020 May; 125():109768. PubMed ID: 32106387
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cells play a potential role in regulating the establishment and maintenance of epithelial-mesenchymal transition in MCF7 human breast cancer cells by paracrine and induced autocrine TGF-β.
Xu Q; Wang L; Li H; Han Q; Li J; Qu X; Huang S; Zhao RC
Int J Oncol; 2012 Sep; 41(3):959-68. PubMed ID: 22766682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
